Future studies should investigate the functional role of the IGFBP-3 A-202C polymorphism in breast cancer biology, assess its utility in combination with other genetic markers for risk prediction, and examine its impact on IGFBP-3 and IGF-1 expression to elucidate the underlying mechanisms contributing to breast cancer development. This evidence concerns the gene IGFBP3 and breast cancer.